Researchers make strides in the fight against COVID-19
Posted: 9 November New research from the Peter Doherty Institute of Infection and Immunity (Doherty Institute), The University of Melbourne and WEHI has unlocked key information in our understanding of molecular immune responses to COVID-19. Following COVID-19 infection,…
Virus discovery could help fight cancer
Posted: 9 November In a world first, La Trobe University researchers have discovered a virus that attacks a prominent disease-causing bacterium – a “ringleader” that recruits harmful bacteria to cause periodontitis, and potentially helps cancer grow and spread.…
Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Cutaneous T-Cell Lymphoma
Posted: 8 November The Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced that they have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-001) for the…
Monash and Hudson Institute teams’ world-first for newborns
Posted: 4 November Melbourne scientists have discovered a way to treat seizures in newborns that will not only help protect their developing brain from further injury, but may also provide the first new, safe and effective treatment in decades.…
Landmark study finds home screening test can help prevent type 1 diabetes
Posted: 4 November Researchers have shown that a blood test for early diagnosis of type 1 diabetes can prevent serious illness and hospitalisation in children. The innovative test is a finger prick sample that is collected at home and…
CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology
Posted: 4 November CSL Limited announced that its subsidiary, CSL Seqirus, has entered into a collaboration and license agreement with Arcturus Therapeutics Holdings Inc to access their late stage self-amplifying mRNA (sa-mRNA) vaccine platform technology. Arcturus Therapeutics is…
VivaZome executives to present at Annual Exosome Scientific Conference
Posted: 4 November VivaZome Therapeutics Pty Ltd (VivaZome) has announced that Ms Xenia Sango, Head of Regulatory and Clinical is speaking at Australia and New Zealand Society for Extracellular Vesicles (ANZSEV) in Gold Coast, Queensland 9 – 11…
Health and the 2022-23 Federal Budget
Posted: 3 November Federal Treasurer Jim Chalmers recently delivered the 2022-2023 Budget. He announced new public health initiatives in Australia and increases in funding for foreign aid, regional and global health, climate change and the environment. Australian Global…
AdAlta expands disease areas for AD-214 applications
Posted: 3 November AdAlta Ltd (ASX:1AD) has made substantial progress in expanding the potential disease areas (indications) and routes of delivery for AD-214 – its lead program and a first in class antifibrotic. The applications of AD-214 have…
Oncology One Supports Zero Childhood Cancer National Symposium as Translational Award Partner
Posted: 25 October Oncology One Pty Ltd has announced it will provide funding for an award at the Childhood Cancer National Symposium being hosted in Sydney from 26-27 October 2022. Consistent with Oncology One’s focus on supporting early-stage…
RMIT supercomputer fast-tracking research opens for business
Posted: 24 October Australia’s first university cloud supercomputing facility, which allows researchers to test ideas and solutions up to 80 times faster than existing on-site servers, is now open to industry partners. RMIT University’s AWS Cloud Supercomputing facility, or…
